Anlotinib Hydrochloride Combined With Capeox in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer

Summary

Prospectively Investigate the effectiveness and safety of anlotinib hydrochloride combined with Capeox in neoadjuvant treatment of patients with locally advanced rectal cancer.

Timeline

Start

2023-11-01

Primary completion

2023-12-01

Completion

2024-10-01

Outcome

Outcome not reported

Stopped: “No approval from ethical committee”

Drugs

Indications